Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 4/5/15  and contains information from public web pages.

Dr. Beth-Ann Lesnikoski

Wrong Dr. Beth-Ann Lesnikoski?

Medical Director

Local Address:  Palm Beach , Florida , United States
Breast Institute at JFK Medical Center

Employment History

  • Medical Director
    Breast Institute at the JFK Medical Center
  • Staff Surgeon
    Palms West Hospital
  • Staff Surgeon
    Faulkner Hospital Brigham & Women's Hospital and Dana Farber Cancer Institute
  • American College of Surgeons

Board Memberships and Affiliations

  • Volunteer Assistant Professor
    University of Miami ( FL ) Miller School of Medicine
  • Member
    Yale Alumni Association
  • FACS


  • MD
    Temple University School of Medicine
  • BA
    Yale University
13 Total References
Web References
Having to undergo a second lumpectomy ..., 5 April 2015 [cached]
Having to undergo a second lumpectomy - something that happens in 20 percent of lumpectomy cases - adds to a patient's mental strain, according to breast surgeon Dr. Beth-Ann Lesnikoski, medical director of the Breast Institute at JFK Medical Center in Atlantis.
"The additional surgery is very minor, but it's an additional surgery. And it's more time the patient feels that she might have cancer in her body," she said.
Lesnikoski began using the device a month ago and has used it during 10 lumpectomies.
The device's analysis of a tumor's edges (or margins) is complete in about five minutes. When an alert indicates cancer may be present at a tumor's edges, the surgeon will, most often, remove more tissue at the corresponding spot in the body, according to Lesnikoski. That prevents the need for a second surgery in many cases, she said. The surgeon said she has ignored the device's alert only once, because she knew from years of experience that a particular mass highlighted by the device was not cancer.
She said she's "very impressed" with the device. "It's fantastic.
Using radio waves, the device scans removed breast tissue from all angles to determine whether cancer remains at any of its margins, Lesnikoski said. The waves pass through normal breast tissue at a different rate than they do cancerous tissue, she explained.
The diagnostic imaging device, approved by the FDA in 2013, produces a different sound when cancer is detected than it does when tissue margins appear free of cancer, she said. MarginProbe also activates a blue light for a negative (clear) reading and a red light for a positive one.
"If it comes back positive, the circulating nurse can make a notation that very precisely tells you where to take more tissue," Lesnikoski said.
Younger women and women on hormone replacement therapy tend to have denser tissue, Lesnikoski said.
The JFK physician said women in those categories should consider whole-breast ultrasound, magnetic resonance imaging or molecular breast imaging (which use a radioactive tracer) when scheduling screenings. Effective screening is critical to reducing deaths caused by breast cancer, she said.
With most women, the standard mammogram - a low-dose X-ray scan - can identify tumors too small to detect by hand, as well as tiny deposits of calcium that could signal the presence of cancer. The United States Preventive Task Force recommends that women ages 50 to 74 get a mammogram every two years. Women with a family history of breast cancer might want to consider starting mammograms earlier.
"It's not perfect, but it's the best tool we have," Lesnikoski said.
American College of Surgeons: NAPBC Surveyor Profiles, 8 Mar 2014 [cached]
Beth-Ann Lesnikoski, MD, FACS
Photo of Beth-Ann Lesnikoski, MD, FACS
Beth-Ann Lesnikoski, MD, FACS
Dr. Lesnikoski is a general surgeon, who received her medical degree from Temple University School of Medicine, Philadelphia, PA, and completed her internship in General Surgery at the Deaconess/Harvard Surgical Service, Boston, MA. She went on to complete her surgical residency at Swedish Hospital in Seattle, WA, and at the Deaconess/Harvard Surgical Service, where she undertook her chief residency. Dr. Lesnikoski completed a fellowship in diseases of the breast at the Faulkner Breast Centre, Faulkner Hospital in Boston, MA.
Dr. Lesnikoski is a volunteer assistant professor at the University of Miami (FL) Miller School of Medicine, a lecturer for the Florida Atlantic University Medical School, and holds an academic appointment as instructor at Harvard Medical School. In addition to serving as medical director of the Breast Institute at the JFK Medical Center in Atlantis, FL, she is a staff surgeon at the Palms West Hospital in Loxahatchee, FL, as well as Faulkner Hospital Brigham & Women's Hospital, and Dana Farber Cancer Institute, all located in Boston. She enjoys bicycling, gardening, and traveling when time permits.
Dr. Beth-Ann Lesnikoski, MD, ..., 4 June 2013 [cached]
Dr. Beth-Ann Lesnikoski, MD, FACS is recognized by Continental Who's Who as a Pinnacle Woman of the Year
Beth-Ann Lesnikoski , MD, FACS is recognized by Continental Who's Who as a Pinnacle Woman of the Year in the field of Healthcare as a result of her role as Medical Director with The Breast Institute at JFK Medical Center.
Dr. Lesnikoski is a Harvard trained surgeon who completed a specialized breast fellowship. She moved to Palm Beach County after practicing at such prestigious institutions as Dana Farber Cancer Center, Brigham and Women's Hospital and Beth Israel Deaconess Hospital between 1996 and 2011.  She specializes in oncoplastic breast surgery and innovative approaches to breast cancer treatment.
Dr. Lesnikoski completed an Internship with Deaconess/Harvard Surgical Service in Boston, Massachusetts and served as a Clinical Fellow in Diseases of the Breast at Faulkner Breast Center, Faulkner Hospital. Furthermore, she completed a Research Fellowship in Surgical Research and Transplantation Immunology at Sandoz Center for Immunobiology, also in Boston.
Dr. Lesnikoski earned her MD at Temple University School of Medicine located in Philadelphia, Pennsylvania. In addition, she holds a BA from Yale University in New Haven, Connecticut. She is currently a member of the Yale Alumni Association; American Cancer Society; American College of Surgeons; as well as a Fellow of the American Society of Breast Surgeons.
As a result of her dedication and professionalism within the field of Healthcare, Dr. Lesnikoski has been named as one of Castle Connolly Top Doctors in 2012 and 2013, given to physicians who are among the top 1% in the nation in his or her specialty. She was a member of the Brigham & Women's/Faulkner Hospital/Harvard Business School Physician Leadership Program from 2008-2009. She received the Curtis Prout Fellowship in Medical Education in 2007.
Dr. Lesnikoski has been honored by the Palm Beach County Medical Society as Project Access Surgical Physician of the Year in 2012, for her outreach work to the underserved community. She also facilitated the opening of the first Palm Beach County site for the Florida Breast and Cervical Cancer Early Detection Program for low income women.
Dr. Lesnikoski has a strong interest and expertise in quality and innovation in healthcare. She is invited to speak around the U.S. because of her experience in developing interdisciplinary breast and cancer programs throughout her career. She has been a surveyor for the American College of Surgeons National Accreditation Program for Breast Centers since 2010.
"This allows us to not only ... [cached]
"This allows us to not only provide a cohesive treatment plan but offers education and support to the patient at a trying time," explains Beth-Ann Lesnikoski, MD, FACS, Medical Director of the Breast Institute. " Just knowing that all the key members of the patient's care team are working together, communicating with one another, and are with her every step of the way, does a lot to lessen anxiety."
Dr. Lesnikoski, a fellowship trained breast surgeon since 1996, was previously associated with Harvard University-affiliated hospitals in Boston, Massachusetts, where she worked in an interdisciplinary breast clinic setting
Tags: Beth-Ann Lesnikoski, Bone Density Scanning, Breast Cancer, Breast Institute, JFK Medical Center, MD; Digital Mammography, Multidisciplinary Breast Clinics, Stereotactic Breast Biopsy, Ultrasound |
Dr. Beth-Ann Lesnikoski will ..., 4 Oct 2007 [cached]
Dr. Beth-Ann Lesnikoski will speak about the importance of early detection of breast cancer and its ongoing prevention at 10 a.m. Oct. 21 as part of MorseLife's ongoing physician lecture series, Voices in Medicine.
Lesnikoski, medical director of the Breast Institute at JFK Medical Center in Atlantis, specializes in oncoplastic breast surgery.
Other People with the name "Lesnikoski":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.